Tag: FDA panel
-
Antidepressants in Pregnancy: FDA Panel Debate and Lifeline
Overview: A Policy Debate Meets Real-World Need Media coverage has highlighted a tense moment as an FDA advisory panel scrutinized the safety of antidepressants used during pregnancy. The conversations, while focused on risk assessment, are ultimately about the daily realities faced by pregnant people and new mothers who struggle with depression or anxiety. Health professionals…
-
Antidepressants in Pregnancy: FDA Panel Questions vs Docs
FDA Panel Questions Antidepressants in Pregnancy In a recent session, members of an FDA advisory panel scrutinized the safety and necessity of using antidepressants during pregnancy. The discussions highlighted the ongoing tension between ensuring fetal safety and acknowledging the real-world needs of pregnant people who experience depression or anxiety. While some panelists raised concerns about…
-
Antidepressants in Pregnancy: FDA Panel Debate vs. Doctors’ Lifeline
FDA Panel Raises Questions About Antidepressants in Pregnancy In recent sessions, a panel of federal and medical experts scrutinized the use of antidepressants by pregnant individuals. The discussion centered on balancing potential risks to developing fetuses with the clear benefits these medications can offer to mothers suffering from depression and anxiety during pregnancy. While some…